Exact Sciences Corp

EXAS

Company Profile

  • Business description

    Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

  • Contact

    5505 Endeavor Lane
    MadisonWI53719
    USA

    T: +1 608 284-5700

    E: [email protected]

    https://www.exactsciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    7,000

Stocks News & Analysis

etfs

ARK Innovation ETF has likely been a disappointment for most investors

Investors are fleeing for the exits amid the fund's underperformance this year.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,133.106.200.08%
CAC 407,837.5038.86-0.49%
DAX 4022,317.64222.34-0.99%
Dow JONES (US)41,989.9611.80-0.03%
FTSE 1008,579.1255.68-0.64%
HKSE23,202.534.31-0.02%
NASDAQ17,449.89150.600.87%
Nikkei 22535,725.87101.390.28%
NZX 50 Index12,320.197.590.06%
S&P 5005,633.0721.220.38%
S&P/ASX 2007,934.509.300.12%
SSE Composite Index3,350.131.690.05%

Market Movers